Document is current
Any future updates will be listed below
-
Authors
Ohki, Kentaro https://orcid.org/0000-0003-2838-4555
Butler, Ellie R.
Kiyokawa, Nobutaka
Hirabayashi, Shinsuke
Bergmann, Anke K.
Möricke, Anja
Boer, Judith M. https://orcid.org/0000-0003-4848-7789
Cavé, Hélène https://orcid.org/0000-0003-2840-1511
Cazzaniga, Giovanni
Yeoh, Allen Eng Juh
Sanada, Masashi https://orcid.org/0000-0003-0666-1996
Imamura, Toshihiko
Inaba, Hiroto https://orcid.org/0000-0003-0605-7342
Mullighan, Charles G. https://orcid.org/0000-0002-1871-1850
Loh, Mignon L.
Norén-Nyström, Ulrika https://orcid.org/0000-0001-5606-5442
Shih, Lee-Yung https://orcid.org/0000-0003-1866-7922
Zaliova, Marketa https://orcid.org/0000-0002-1639-7124
Pui, Ching-Hon https://orcid.org/0000-0003-0303-5658
Haas, Oskar A. https://orcid.org/0000-0001-7334-454X
Harrison, Christine J.
Moorman, Anthony V. https://orcid.org/0000-0002-9781-6107
Manabe, Atsushi
- License Information
-
More Information
Article History
Received: 3 August 2022
Revised: 12 October 2022
Accepted: 14 October 2022
First Online: 29 October 2022
Competing interests
: CGM: Research support from Loxo, Abbvie, Pfizer. Consulting and speaking fees from Amgen, Illumina. C-HP received consulting and speaker fees from Amgen, Erytech Phamra, and Servier. HI received a research grant from Servier. AVM: Honoria for speaking from Amgen.
